The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

CardioMEMS, Inc. wins 2012 Intel Innovation Award

December 11, 2012 10:56 am | by The Associated Press | News | Comments

CardioMEMS, Inc., an Atlanta-based medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that it has been honored as the 2012 recipient of the Intel Innovation Award.  Founder and...

Navidea Biopharmaceuticals Provides Financing Update

December 11, 2012 10:24 am | by The Associated Press | News | Comments

DUBLIN, Ohio--(BUSINESS WIRE)--Dec 11, 2012--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has closed on an initial draw of $2 million under its line of credit with Platinum-Montaur Life...

SI-BONE Announces 1st Peer Reviewed Journal Publication of iFuse@ and 5,000 Patients Treated Milestone

December 11, 2012 10:01 am | by The Associated Press | News | Comments

SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to fuse the sacroiliac (SI) joint announced today the publication of the first peer-reviewed journal article on the iFuse Implant System for the treatment of ...


Collaborators Present Data Supporting Use of Sequenta’s LymphoSIGHT™ Method for Acute Lymphoblastic Leukemia

December 11, 2012 9:00 am | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Dec 11, 2012--Sequenta, Inc. and their collaborators presented data from four new clinical studies in which the LymphoSIGHT™ method demonstrated superior sensitivity in measuring minimal residual disease (MRD) in bone marrow and peripheral blood from acute...

Medifocus Inc. Announces Increase in Size of Units Offering

December 11, 2012 8:33 am | by The Associated Press | News | Comments

Medifocus Inc. (TSX VENTURE: MFS)(OTCQX: MDFZF) (Medifocus or the Company) announces that, due to investor demand, it intends to increase the size of the non-brokered private placement of units (the Offering) announced on November 30, 2012. Medifocus intends to increase the Offering from up...

Novella Clinical Bolsters Business Development with Three New Hires

December 11, 2012 8:00 am | by The Associated Press | News | Comments

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Dec 11, 2012--Novella Clinical, a full service contract research organization (CRO), today announced an expanded business development team with the addition of three Directors of Client Service: Pamela Kennedy, RN; Fabio Mariano and Matthew O’Rourke. ...

Fiscal cliff debates bring more talk of medtech tax repeal | On Call

December 11, 2012 7:29 am | by Mass Device | News | Comments

Opponents of the 2.3% medical device tax are looking for opportunities to address their concerns during the Congressional debates of the so-called "fiscal cliff." The discussions may be gaining momentum as more voices in the House and Senate call for either repeal or delay in implementation for the tax, which takes effect January 1.

Sequenom Announces Leadership Appointments

December 11, 2012 7:01 am | by The Associated Press | News | Comments

Sequenom, Inc. (Nasdaq: SQNM) announced today the appointments of William Welch as the Company's President and Chief Operating Officer and Dirk van den Boom as the Company's Executive Vice President, Research & Development and Chief Technology Officer, both effective immediately. ...


European Journal of Heart Failure Lauds BioControl Medical’s Research on Vagus Nerve Stimulation for Treating HF

December 11, 2012 7:00 am | by The Associated Press | News | Comments

YEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--Dec 11, 2012--BioControl Medical has announced that the pilot clinical study of its CardioFit® vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure. According to a recent...

Moximed Initiates US Clinical Study with KineSpring® System in Patients with Knee Osteoarthritis

December 11, 2012 7:00 am | by The Associated Press | News | Comments

HAYWARD, Calif.--(BUSINESS WIRE)--Dec 11, 2012--Moximed, Inc. announced today that the KineSpring ® System, an implantable medical spring that works by unloading the weight on the diseased knee joint, has been successfully implanted in the first patient enrolled in its US clinical study, SOAR. ...

Genomic Research Service Provider DNA Link Purchases 10 Ion Proton Sequencers

December 11, 2012 6:01 am | by The Associated Press | News | Comments

Life Technologies Corporation (NASDAQ: LIFE) today announced that DNA Link Inc., a Korean genomic research service provider, has placed an order to purchase ten Ion ProtonT Sequencers, which are shipping immediately. To watch a short interview with DNA Link's CEO, Dr. Jong Eun Lee, click...

Alliance for Cancer Gene Therapy Funds Promising Leukemia Study – Patients in Remission More Than Two Years after Gene Therapy Treatment at UPenn

December 10, 2012 11:21 pm | by The Associated Press | News | Comments

STAMFORD, Conn.--(BUSINESS WIRE)--Dec 10, 2012--Alliance for Cancer Gene Therapy ( ACGT ), the nation’s only non-profit organization dedicated exclusively to funding cell and gene therapy research for cancer, is excited to play a major role in the recent leukemia study pioneered by scientists at...

Funding: InSightec closes $30.9 million Series C round

December 10, 2012 6:00 pm | by Mass Device | News | Comments

InSightec picked off $30.9 million in a Series C financing round, led by a $27.6 million investment from GE Healthcare and $3.3 million by other investors, the company said. In addition, the Israeli-based ultrasound maker also named VP & general manager of the MRI business James Davis as new CEO and Tom Gentile as chairman of board.

Enzo Biochem Reports First Quarter Results

December 10, 2012 4:42 pm | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Dec 10, 2012--Enzo Biochem, Inc. (NYSE:ENZ) today reported results for the fiscal first quarter ended October 31, 2012. Recent highlights included: Favorable patent infringement ruling in which the court awarded the Company $48.5...

aap Implantate AG Receives FDA 510(k) Clearance for LOQTEQ Trauma Plating System

December 10, 2012 3:36 pm | News | Comments

aap Implantate AG, a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, announced that the first six systems of the LOQTEQ® Trauma Plating family of products has received 510(k) clearance from the U.S. Food & Drug Administration (FDA), following clearance of the first LOQTEQ® product in August 2012.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.